Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin D Cooper

Showing results (111-120 of 131) with videos related to

Pageof 14
Sort By:
Photodermatology, Photoimmunology & Photomedicine|February 28, 2020
Comparison of racial distribution of photodermatoses in USA academic dermatology clinics: A multicenter retrospective analysis of 1080 patients over a 10-year periodRemi Hamel, Tasneem F Mohammad, Adam Chahine, et al.
Ebiomedicine|November 25, 2024
NF-κB c-Rel is a critical regulator of TLR7-induced inflammation in psoriasisAngela Rose Liu, Nandini Sarkar, Jordan D Cress, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2006
An anti-IL-12p40 antibody down-regulates type 1 cytokines, chemokines, and IL-12/IL-23 in psoriasisEiko Toichi, Gisela Torres, Thomas S McCormick, et al.
The Journal of Investigative Dermatology|March 2, 2024
Circulating Monocytes Are Predictive and Responsive in Moderate-to-Severe Plaque Psoriasis Subjects Treated with ApremilastEmma L Larson, Dustin P DeMeo, Andrew B Young, et al.
Frontiers in Oncology|June 1, 2012
Preliminary clinical and pharmacologic investigation of photodynamic therapy with the silicon phthalocyanine photosensitizer pc 4 for primary or metastatic cutaneous cancersTimothy James Kinsella, Elma D Baron, Valdir C Colussi, et al.
The Journal of Investigative Dermatology|December 22, 2004
A phase I study evaluating the safety, pharmacokinetics, and clinical response of a human IL-12 p40 antibody in subjects with plaque psoriasisCatharine L Kauffman, Nancy Aria, Eiko Toichi, et al.
Journal of the American Academy of Dermatology|February 28, 2004
Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association "Administrative Regulations for Evidence-Based Clinical Practice Guidelines"Jon M Hanifin, Kevin D Cooper, Vincent C Ho, et al.
Archives of Dermatology|January 18, 2012
Phase I clinical trial of O6-benzylguanine and topical carmustine in the treatment of cutaneous T-cell lymphoma, mycosis fungoides typeNarin Apisarnthanarax, Gary S Wood, Seth R Stevens, et al.
Photochemistry and Photobiology|January 29, 2008
Apoptosis mechanisms related to the increased sensitivity of Jurkat T-cells vs A431 epidermoid cells to photodynamic therapy with the phthalocyanine Pc 4Malcolm S Ke, Liang-yan Xue, Denise K Feyes, et al.
Journal of the American Academy of Dermatology|January 24, 2020
Modernizing clinical practice guidelines for the American Academy of DermatologyEsther E Freeman, Devon E McMahon, Matthew Fitzgerald, et al.
Pageof 14

Showing results (111-120 of 131) with videos related to

Sort By:
Pageof 14
Photodermatology, Photoimmunology & Photomedicine|February 28, 2020
Comparison of racial distribution of photodermatoses in USA academic dermatology clinics: A multicenter retrospective analysis of 1080 patients over a 10-year periodRemi Hamel, Tasneem F Mohammad, Adam Chahine, et al.
Ebiomedicine|November 25, 2024
NF-κB c-Rel is a critical regulator of TLR7-induced inflammation in psoriasisAngela Rose Liu, Nandini Sarkar, Jordan D Cress, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2006
An anti-IL-12p40 antibody down-regulates type 1 cytokines, chemokines, and IL-12/IL-23 in psoriasisEiko Toichi, Gisela Torres, Thomas S McCormick, et al.
The Journal of Investigative Dermatology|March 2, 2024
Circulating Monocytes Are Predictive and Responsive in Moderate-to-Severe Plaque Psoriasis Subjects Treated with ApremilastEmma L Larson, Dustin P DeMeo, Andrew B Young, et al.
Frontiers in Oncology|June 1, 2012
Preliminary clinical and pharmacologic investigation of photodynamic therapy with the silicon phthalocyanine photosensitizer pc 4 for primary or metastatic cutaneous cancersTimothy James Kinsella, Elma D Baron, Valdir C Colussi, et al.
The Journal of Investigative Dermatology|December 22, 2004
A phase I study evaluating the safety, pharmacokinetics, and clinical response of a human IL-12 p40 antibody in subjects with plaque psoriasisCatharine L Kauffman, Nancy Aria, Eiko Toichi, et al.
Journal of the American Academy of Dermatology|February 28, 2004
Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association "Administrative Regulations for Evidence-Based Clinical Practice Guidelines"Jon M Hanifin, Kevin D Cooper, Vincent C Ho, et al.
Archives of Dermatology|January 18, 2012
Phase I clinical trial of O6-benzylguanine and topical carmustine in the treatment of cutaneous T-cell lymphoma, mycosis fungoides typeNarin Apisarnthanarax, Gary S Wood, Seth R Stevens, et al.
Photochemistry and Photobiology|January 29, 2008
Apoptosis mechanisms related to the increased sensitivity of Jurkat T-cells vs A431 epidermoid cells to photodynamic therapy with the phthalocyanine Pc 4Malcolm S Ke, Liang-yan Xue, Denise K Feyes, et al.
Journal of the American Academy of Dermatology|January 24, 2020
Modernizing clinical practice guidelines for the American Academy of DermatologyEsther E Freeman, Devon E McMahon, Matthew Fitzgerald, et al.
Pageof 14